X-ray sensitization by halopyrimidines.
D001932:Brain Neoplasms / Q000628:therapy; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002477:Cells / Q000528:radiation effects; D004247:DNA / Q000096:biosynthesis / Q000528:radiation effects; D004273:DNA, Neoplasm / Q000096:biosynthesis / Q000528:radiation effects*; D003857:Deoxyuridine / Q000494:pharmacology; D004307:Dose-Response Relationship, Radiation; D005467:Floxuridine / Q000494:pharmacology; D006219:Halogens; D006801:Humans; D007065:Idoxuridine / Q000494:pharmacology; D007269:Injections, Intra-Arterial; D009369:Neoplasms / Q000532:radiotherapy; D011742:Pyrimidine Nucleotides / Q000378:metabolism / Q000494:pharmacology*; D011830:Radiation Effects; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage / Q000494:pharmacology*; D013936:Thymidine / Q000494:pharmacology
D004273:DNA, Neoplasm; D006219:Halogens; D011742:Pyrimidine Nucleotides; D011838:Radiation-Sensitizing Agents; D005467:Floxuridine; D004247:DNA; D001973:Bromodeoxyuridine; D007065:Idoxuridine; D013936:Thymidine; D003857:Deoxyuridine